State Street’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,885,944
| Closed | -$122M | – | 4649 |
|
|
2023
Q2 | $122M | Buy |
2,885,944
+31,564
| +1% | +$1.28M | 0.01% | 1090 |
|
|
2023
Q1 | $102M | Buy |
2,854,380
+46,991
| +2% | +$1.71M | 0.01% | 1176 |
|
|
2022
Q4 | $103M | Buy |
2,807,389
+101,109
| +4% | +$4M | 0.01% | 1143 |
|
|
2022
Q3 | $128M | Buy |
2,706,280
+45,731
| +2% | +$2.95M | 0.01% | 965 |
|
|
2022
Q2 | $191M | Buy |
2,660,549
+129
| +0% | +$9.43K | 0.01% | 761 |
|
|
2022
Q1 | $215M | Buy |
2,660,420
+61,351
| +2% | +$5.19M | 0.01% | 796 |
|
|
2021
Q4 | $267M | Buy |
2,599,069
+82,093
| +3% | +$7.88M | 0.01% | 728 |
|
|
2021
Q3 | $220M | Buy |
2,516,976
+67,483
| +3% | +$6.11M | 0.01% | 785 |
|
|
2021
Q2 | $219M | Buy |
2,449,493
+619,006
| +34% | +$52.3M | 0.01% | 805 |
|
|
2021
Q1 | $139M | Buy |
1,830,487
+183,664
| +11% | +$13.8M | 0.01% | 994 |
|
|
2020
Q4 | $112M | Buy |
1,646,823
+165,512
| +11% | +$10.3M | 0.01% | 1059 |
|
|
2020
Q3 | $78.7M | Buy |
1,481,311
+4,895
| +0.3% | +$291K | 0.01% | 1132 |
|
|
2020
Q2 | $86M | Sell |
1,476,416
-506,022
| -26% | -$27.2M | 0.01% | 1070 |
|
|
2020
Q1 | $78.1M | Sell |
1,982,438
-11,396
| -0.6% | -$666K | 0.01% | 979 |
|
|
2019
Q4 | $119M | Sell |
1,993,834
-14,818
| -0.7% | -$797K | 0.01% | 938 |
|
|
2019
Q3 | $107M | Sell |
2,008,652
-131,305
| -6% | -$6.74M | 0.01% | 964 |
|
|
2019
Q2 | $109M | Buy |
2,139,957
+52,574
| +3% | +$2.45M | 0.01% | 981 |
|
|
2019
Q1 | $108M | Buy |
2,087,383
+61,911
| +3% | +$3M | 0.01% | 958 |
|
|
2018
Q4 | $79.7M | Sell |
2,025,472
-95,376
| -4% | -$4.43M | 0.01% | 1038 |
|
|
2018
Q3 | $109M | Buy |
2,120,848
+179,938
| +9% | +$8.81M | 0.01% | 1013 |
|
|
2018
Q2 | $91M | Buy |
1,940,910
+117,440
| +6% | +$4.86M | 0.01% | 1103 |
|
|
2018
Q1 | $64.7M | Sell |
1,823,470
-249,499
| -12% | -$9.77M | 0.01% | 1263 |
|
|
2017
Q4 | $90.4M | Buy |
2,072,969
+213,972
| +12% | +$10M | 0.01% | 1084 |
|
|
2017
Q3 | $97.2M | Buy |
1,858,997
+89,644
| +5% | +$5M | 0.01% | 997 |
|
|
2017
Q2 | $104M | Buy |
1,769,353
+937,864
| +113% | +$48.7M | 0.01% | 953 |
|
|
2017
Q1 | $38.1M | Buy |
831,489
+6,742
| +0.8% | +$335K | ﹤0.01% | 1490 |
|
|
2016
Q4 | $43.4M | Buy |
824,747
+58,549
| +8% | +$2.83M | ﹤0.01% | 1353 |
|
|
2016
Q3 | $34.2M | Buy |
766,198
+71,814
| +10% | +$3.11M | ﹤0.01% | 1431 |
|
|
2016
Q2 | $26.5M | Buy |
694,384
+393,144
| +131% | +$17.3M | ﹤0.01% | 1554 |
|
|
2016
Q1 | $12.4M | Buy |
301,240
+9,348
| +3% | +$385K | ﹤0.01% | 2044 |
|
|
2015
Q4 | $14.2M | Buy |
291,892
+8,238
| +3% | +$366K | ﹤0.01% | 1971 |
|
|
2015
Q3 | $11.3M | Buy |
283,654
+96,255
| +51% | +$4.2M | ﹤0.01% | 2104 |
|
|
2015
Q2 | $7.52M | Buy |
187,399
+79,783
| +74% | +$2.75M | ﹤0.01% | 2421 |
|
|
2015
Q1 | $3.52M | Buy |
107,616
+33,072
| +44% | +$913K | ﹤0.01% | 2760 |
|
|
2014
Q4 | $1.92M | Buy |
+74,544
| New | +$1.77M | ﹤0.01% | 3064 |
|
Other funds holding SYNH
IA
BTI
CFB
HNB
State Street's SYNH Position: Q3 2023 in Review
State Street sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 2,885,944 shares — an estimated $122M sold.
State Street first reported a position in SYNH in Q4 2014 and held it in 35 quarters. The position peaked at $267M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.
- State Street reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- State Street sold 2,885,944 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $122M.
- State Street first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 35 quarters.
- State Street's Syneos Health, Inc. Class A Common Stock position peaked at $267M in Q4 2021.
- 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.
Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.